FDA clears Median Technologies’ lung nodule evaluation software
FDA approval for eyonis LCS was supported by data from Median’s RELIVE (NCT06751576) pivotal trial, which met its primary endpoint,...
nodule
FDA clears RevealDX’s AI lung nodule diagnostic
RevealAI-Lung is now reimbursable in the US under the Medicare Outpatient Prospective Payment System (OPPS) at a rate of $650....
Emory Healthcare launches new Lung Screening and Nodule Program
Winship Cancer Institute of Emory University is advancing its commitment to reducing lung cancer deaths across Georgia with the launch...
Patient and nodule characteristics associated with adherence to lung cancer screening in a large integrated healthcare system
Data source and study populationWe obtained 2012–2021 patient-level EHR data from the University of Florida (UF) Health Integrated Data Repository...
